Stocks
IGM Biosciences (IGMS) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -20 756% | -11 895% | -7 834% | |||||
| Changes by years, y/y, % | +8 861pp | -42.7% | |||||||
IGM Biosciences. EBITDA margin, %
IGM Biosciences. EBITDA margin, changes, pp
IGM Biosciences (IGMS) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -12 672% | -9 746% | -10 398% | -3 914% | -12 478% | -7 834% | |
| Changes by years, y/y, % | +5 154pp | +5 379pp | +1 423pp | +10 826pp | +194pp | |||
| Changes by quarters, q/q, % | +2 068pp | +2 926pp | -652pp | +6 484pp | -8 564pp | |||
